Overview
Status
Suspended
Registry date
2011-10-18
Share capital
20,000.00 PLN
Registered address
Aleja Stanów Zjednoczonych 61A, 04-028 Warszawa, Poland
Electronic delivery address
AE:PL-48862-12346-VUETV-30
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 90 days for 2021).
- 2025not filed
- 202415/07/2025
- 202322/05/2024
- 202218/07/2023
- 202113/10/2022
- 202014/05/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Artur Michał Jasiński – President of the Management Board
Manner of representation
In the case of a one-person management board, the President of the Management Board independently. In the case of a multi-member management board, each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Artur Michał Jasińskiage 49 | 400 | $5,402.49 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2022-11-01 to 2024-06-30.
Reason for removal: Art. 96 ust. 6-8
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-19 | Business suspended | |
| 2023-01-27 | Address change (Ul. Tomasza Zana 4, 04-313, Warszawa → Aleja Stanów Zjednoczonych 61a, 04-028, Warszawa) | |
| 2023-01-27 | PKD change (Added: 45.11.Z, 46.52.Z) | |
| 2022-06-24 | Name change (Hydrex Diagnostics → Diagnostics) | |
| 2018-10-06 | Address change (Śmiała 30/1, 01-523, Warszawa → Ul. Tomasza Zana 4, 04-313, Warszawa) |
FAQ
The main business activity of Diagnostics focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on October 18, 2011.
The headquarters is located at: Aleja Stanów Zjednoczonych 61A, 04-028 Warszawa.
The share capital of the company is PLN 20,000 (approx. $5,402).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07